文献速递肿瘤 PET/CT

FDG PET/CT代谢参数在早期肺腺癌分类中的价值:预测病理浸润大小

Utility of Metabolic Parameters on FDG PET/CT in the Classification of Early-Stage Lung Adenocarcinoma: Prediction of Pathological Invasive Size.
PubMed 文献 · Clin Nucl Med · 2019-01-01

结果显示MTD1.0与IS相关性最强(r=0.725),基于MTD1.0的临床分期与病理分期重复性为中等偏强(k=0.676),优于基于SS的分期(k=0.529)。

要点

  • MTD1.0与病理浸润大小的相关性显著优于SS和SUVmax。
  • 基于MTD1.0的临床T分期与病理分期重复性优于基于薄层CT实性大小。
  • FDG PET/CT代谢参数有助于更精确分类早期肺腺癌。

核心结论

  • FDG PET/CT的MTD1.0与肺腺癌病理浸润大小显著相关且强于薄层CT的SS。
  • FDG PET/CT可比基于薄层CT的T分类更精确地分类早期肺腺癌。

研究设计与样本

  • 记录薄层CT实性大小(SS)和病理浸润大小(IS)。
  • 测量SUVmax和MTV1.0,并自动计算MTD1.0。
  • 用Pearson相关系数比较IS与SS、SUVmax、MTD1.0的相关性。
  • 用kappa系数分析基于SS或MTD1.0的临床分期与病理分期的重复性。

主要发现

  • IS与SS的Pearson相关系数为0.630。
  • IS与SUVmax的Pearson相关系数为0.600。
  • IS与MTD1.0的Pearson相关系数为0.725。
  • MTD1.0与IS的相关性显著强于SS(P=0.040)和SUVmax(P=0.008)。
  • 基于SS的临床分期与病理分期重复性为中等(k=0.529,P<0.001),基于MTD1.0为中等偏强(k=0.676,P<0.001)。

临床怎么用

  • 在早期肺腺癌术前评估中,可考虑用FDG PET/CT的MTD1.0辅助判断病理浸润大小。
  • MTD1.0可能帮助优化临床T分类,补充薄层CT实性大小的不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This paper aims to explore the role of a metabolic parameter on F-FDG-PET/CT for clinical T-classification in early-stage adenocarcinoma. PATIENTS AND METHODS: One hundred six surgically resected pathological TNM stage (p-stage) 0/I lung adenocarcinomas were retrospectively reviewed. The solid size (SS) measured on thin-section CT and the pathological invasive size (IS) of tumors were recorded. The SUVmax and metabolic tumor volume with SUV ≥1.0 (MTV1.0) derived from PET/CT data were measured on a workstation, and the metabolic tumor diameter with SUV ≥1.0 (MTD1.0) was calculated automatically from MTV1.0. For the correlations between the IS and the SS, MTD1.0, or SUVmax, Pearson's correlation coefficients were compared using the Meng-Rosenthal-Rubin method. Additionally, the reproducibility between the clinical TNM stage (c-stage), based on the SS or MTD1.0, and the p-stage was analyzed using the kappa coefficient (k). RESULTS: For the correlations between the IS and the other parameters, Pearson correlation coefficient was 0.630 for the SS, 0.600 for the SUVmax, and 0.725 for MTD1.0. MTD1.0 correlated significantly and more strongly with the IS than the SS and the SUVmax did (P = 0.040, and P = 0.008, respectively). The reproducibility between p-stage and c-stage based on the SS was moderate (k = 0.529, P < 0.001), whereas that between p-stage and c-stage based on MTD1.0 was substantial (k = 0.676, P < 0.001). CONCLUSIONS: MTD1.0 on FDG-PET/CT was correlated significantly and more strongly with the pathological IS in lung adenocarcinomas than with the SS on thin-section CT. FDG-PET/CT could classify more precisely early-stage lung adenocarcinoma than the presently used T-classification based on thin-section CT findings.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Iwano S, Ito S, Kamiya S, et al. Utility of Metabolic Parameters on FDG PET/CT in the Classification of Early-Stage Lung Adenocarcinoma: Prediction of Pathological Invasive Size. Clin Nucl Med. 2019. PMID: 31021916. doi:10.1097/RLU.0000000000002591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。